ADITXTREPROGRAMMING
DEAD

Serial Number

90062170

Owner

ADITXT, INC.

Attorney

Jared M. Barrett

Filing Date

Jul 20, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ADITXTREPROGRAMMING Trademark

Serial Number: 90062170

ADITXTREPROGRAMMING is a trademark filed by ADITXT, INC. on July 20, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

ADITXT, INC. (10 trademarks)

Richmond, VA 23219

Entity Type: 03

Aditx Therapeutics, Inc. (8 trademarks)

2569 Wyandotte St., Suite 101
Mountain View, CA 94043

Entity Type: 03

Trademark Details

Filing Date

July 20, 2020

Registration Date

Not Registered

Published for Opposition

May 25, 2021

Goods & Services

Pharmaceutical preparations and therapeutic agents modulating the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells; pharmaceutical preparations and therapeutic agents for inducing immune tolerance

Health care services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic and treatment purposes; advisory services relating to health; providing information in the field of health

Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 26, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 26, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 19, 2023 EXRA
SOU EXTENSION 4 GRANTED
Jul 17, 2023 EX4G
SOU EXTENSION 4 FILED
Jul 17, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jan 17, 2023 EX3G
SOU EXTENSION 3 FILED
Jan 17, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 20, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jul 18, 2022 EX2G
SOU EXTENSION 2 FILED
Jul 18, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 18, 2022 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 23, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 23, 2022 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 23, 2022 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 15, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 13, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 13, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 13, 2022 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 22, 2021 ASGN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 20, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 25, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 25, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 5, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 20, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 19, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 19, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 19, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 19, 2021 CNEA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 30, 2021 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 30, 2021 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 3, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 16, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 16, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 16, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2020 NWOS
NEW APPLICATION ENTERED
Jul 23, 2020 NWAP